In this episode, Matt Neal, Senior Director of Regulatory Affairs Operations at Atara Biotherapeutics, talks about his work introducing innovations to evolve the regulatory operations and submissions space. Matt improved knowledge management and information management at a company, by leading Atara’s transition towards a digital cloud-based database ecosystem that’s accessible and cross-functional.
He explains why these changes can be challenging within the life sciences and why getting leaders to bring new data-centric technologies like AI and natural language processing is crucial for operations to be upgraded. Unfortunately, the industry finds itself behind others, and developing good ideas is still a very slow process, but Matt believes that communication with the patient community, bringing company information to an accessible platform, and standardizing the language in work environments can accelerate the innovation process in life sciences.
Tune in to learn how Matt Neal is getting rid of the waste in Life Sciences to improve the industry!
The Life Sciences Industry is ready to face communication, regulation, and innovation challenges.
Matt Neal joined Atara Biotherapeutics in 2019 as the Head of Regulatory Operations. Prior to that, Matt was the Head of Product Management for the InSight Suite of Regulatory Information Management Solutions at Parexel, Inc., and partnered with Microsoft. Before joining PAREXEL, Matt was a Director of Regulatory & Safety Operations at Amgen, Inc. (2003-2016) and was one of the pioneering members of the Regulatory Submissions Department for GlaxoSmithKline (1996-2003). Matt has been publishing and submitting electronic dossiers to the FDA since 1996 and submitted the very first fully electronic NDA for GSK in 1999.